Skip to main content
S 2691 115th Congress Senate Health Business ethics Business expenses Business records Child health Civil actions and liability Corporate finance and management Department of Health and Human Services Department of Justice Department of Labor Drug safety, medical device, and laboratory regulation Drug trafficking and controlled substances Drug, alcohol, tobacco use Education programs funding Elementary and secondary education Employment taxes Executive agency funding and structure Government information and archives Government studies and investigations Government trust funds

Opioid Crisis Accountability Act of 2018

Introduced: April 17, 2018 Introduced by: Sanders, Bernard Independent · Vermont See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 17, 2018
Read twice and referred to the Committee on Finance.
Apr 17, 2018
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Opioid Crisis Accountability Act of 2018

This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit a drug manufacturer from engaging in illegal marketing and distribution practices, including falsely advertising, promoting, or marketing that an opioid has no addiction-forming or addiction-sustaining qualities or risks.

The bill penalizes drug manufacturers or distributors who illegally advertise, market or distribute an opioid product, including by (1) imposing a civil fine or salary confiscation, (2) revoking any remaining period of market exclusivity for such product, (3) requiring reimbursement of federal funding received for such product, and (4) prohibiting certain tax credits.

What's happening now April 17, 2018

Read twice and referred to the Committee on Finance.

 Related & companion bills 1
  • HR 5782 Identical bill Opioid Crisis Accountability Act of 2018
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Democratic 2
D
Blumenthal, Richard
Connecticut · Apr 19, 2018
 D
Gillibrand, Kirsten E.
New York · Apr 19, 2018
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2691: Opioid Crisis Accountability Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-S-2691/
MLA
"S. 2691: Opioid Crisis Accountability Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2691/.
Bluebook (legal)
S. 2691, 115th Cong. (2026), https://openamerica.io/bill/115-S-2691/.
Markdown link
[S. 2691: Opioid Crisis Accountability Act of 2018](https://openamerica.io/bill/115-S-2691/)
Report a problem